|
Endometriosis is a generally benign entity defined as the presence
of endometrial glands in locations outside the uterus. The ectopic
endometrium responds to hormonal stimulation with various degrees
of cyclic hemorrhage that result in suggestive symptoms and appearances.
Endometriosis has an estimated prevalence of 10% in women of reproductive
age. It average age of onset is between the ages of 25 to 29 years
and endometriosis is rarely seen in postmenopausal women. Endometriosis
in women younger than 20 years is often secondary to obstructive
anomalies of the uterus or vagina. The pathogenesis of endometriosis
is debated and there are numerous theories that have been postulated,
including: (1) reflux of endometrial cells through the fallopian
tubes with direct implantation onto pelvic structures; (2) coelomic
metaplasia in which totipotential cells are transformed by repeated
exposure to hormonal stimuli; and (3) vascular dissemination in
which endometrial cells are transported by the blood vessels or
lymphatics. The three hallmarks of endometriosis are peritoneal
endometrial implants, endometriomas (“chocolate” cysts),
and adhesions. The most frequent site of peritoneal involvement
is the ovary, specifically termed endometriomas or endometriotic
cysts. Endometriomas are usually multiple and bilateral. The next
most frequent locations (in order of decreasing frequency) are the
uterine ligaments, pelvic cul-de-sac (pouch of Douglas), pelvic
peritoneum reflected over the uterus, fallopian tubes, rectosigmoid,
and bladder dome. Rare extraperitoneal sites include the lungs and
the central nervous system.
Although endometriosis may be an incidental finding, the most common
symptoms include chronic pelvic pain and infertility, cyclical pain,
dysparenunia, and ovarian masses. Adhesions can obliterate the cul-de-sac,
which correlates with the physical examination finding of a “frozen
pelvis.” Complications of endometriosis include bowel and
ureteral obstruction resulting from endometrial implants, pelvic
adhesions, or mass effect from large endometriomas. Although rare
(1%), malignant transformation can occur, with the most common tumor
types being endometrial carcinoma, clear cell carcinoma, and carcinosarcoma.
Laparoscopy is the standard for the diagnosis and staging of pelvic
endometriosis. Staging of endometriosis depends on the degree and
complications of endometrial implants. The 1985 Revised Classification
of Endometriosis created by the American Society for Reproductive
Medicine evaluated characteristics of endometrial implants, such
as location and depth of penetration, as well as the degree of cul-de-sac
obliteration and adhesions. The findings on laparoscopy can classify
patients into four classes from mild (stage I) to severe (stage
IV). The staging correlates with likelihood of pregnancy but not
with severity of pain. Laparoscopic imaging is limited in endometriosis
in that it can not clearly visualize lesions located in regions
obscured by pelvic adhesions and lesions located in extraperitoneal
sites.
Magnetic resonance (MR) imaging is a promising alternative for
the evaluation of endometriosis before treatment with a demonstrated
a sensitivity between 90 to 92% and specificity between 91 to 98%
for the detection of endometriomas. Endometriomas are thick walled
cysts with extensive surrounding fibrosis and adhesions to adjacent
structures. On T1-weighted images, endometriomas demonstrate homogeneously
high signal intensity, more conspicuous on fat-suppressed T1 weighted
images—which also help differentiate these from fat-containing
lesions. On T2-weighted images, endometriomas demonstrate a gradient
of low signal intensity, termed “shading,” presumably
caused by repeated bleeding and the build-up of blood products,
especially iron, that shorten T2. This T2 shortening is rarely seen
in other masses of any type, e.g. functional or hemorrhagic cysts.
The discrete endometrial implants are more difficult to identify,
although their imaging characteristics are similar to endometriomas.
Some endometrial implants exhibit enhancement after gadolinium.
MR imaging can also demonstrate the complications of endometriosis
including bowel obstructions and hydronephrosis. MR imaging has
limitations, with its main limitation being the detection of small
(< 3 mm) peritoneal implants, as well as atypical implants, identifying
adhesions, and accurate staging of the disease.
Laparoscopic or surgical diagnosis, staging, and treatment are
still often necessary. Treatment for symptomatic endometriosis can
be medical or surgical. Nonsteroidal anti-inflammatory drugs (NSAIDs)
are frequently used first in patients with pelvic pain, particularly
if the diagnosis of endometriosis has not been definitively established.
Oral contraceptives can be used to achieve an anovulatory state.
Laparoscopic surgical approaches to endometriosis include ablation
of implants, lysis of adhesions, removal of endometriomas, uterosacral
nerve ablation, and presacral neurectomy. Conservative surgery can
be performed to preserve fertility in young patients. Definitive
surgery is a hysterectomy and bilateral oophorectomy.
References:
- Semelka, Richard. Abdominal-Pelvic MRI. New York:
Wiley-Liss Inc, 2002. pp. 1139-1147.
- Bahu, A.M. A Practical Guide to Magnetic Resonance Imaging
of Benign Ovarian Conditions. Online Applied Radiology. 2003;
28-35.
- Gougoutas CA, Siegelman ES, et al. Pelvic Endometriosis:
Various Manifestations and MR Imaging Findings. American
Journal of Roentgenology. 2000; 175: 353-358.
- Glastonbury CM. The Shading Sign. Radiology. 2002;
224: 199-201.
- Woodward PJ, Sohaey R, and TP Mezzetti. Endometriosis:
Radiologic-Pathologic Correlation. RadioGraphics. 2001; 21:
193-216.
- Gerety E and RD Harris. Endometriosis: Epidemiology, Current
Pathophysiological Concepts, and Imaging Considerations.
Applied Radiology. 2001 Jan; 11-18.
- Trovato MJ and RA Schwartz. Endometrioma/Endometriosis.
(2001). eMedicine
(04/19/04).
|